Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 2;24(3):61.
doi: 10.1208/s12248-022-00713-1.

A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development

Marilyn N Martinez  1 , Fang Wu  2 , Balint Sinko  3 , David J Brayden  4 , Michael Grass  5 , Filippos Kesisoglou  6 , Aaron Stewart  5   7 , Kiyohiko Sugano  8
Affiliations
Review

A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development

Marilyn N Martinez et al. AAPS J. .

Abstract

It is now recognized that a number of excipients previously considered to be "inert" have the capacity to alter drug oral bioavailability through a range of in vivo effects. The various mechanisms through which an excipient can affect in vivo gastrointestinal physiology and drug absorption characteristics were explored in "A Critical Overview of The Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption." The next critical issue that needs to be discussed is how these biological effects are evaluated. Therefore, in Part 2 of this critical overview, the in vitro, in vivo, and in silico methods for evaluating excipient effects are considered. Examples are provided to illustrate how such studies employing these various procedures have been used to promote formulation understanding and optimization. Finally, a discussion of how the Center for Drug Evaluation and Research applies these tools to support biowaivers is provided.

Keywords: bioavailability; ex vivo methods; excipient effects; in situ methods; in vitro assays; modeling and simulation.

PubMed Disclaimer

References

    1. Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549–72. - PubMed - DOI
    1. Ricarte RG, Van Zee NJ, Li Z, Johnson LM, Lodge TP, Hillmyer MA. Recent advances in understanding the micro- and nanoscale phenomena of amorphous solid dispersions. Mol Pharm American Chemical Society. 2019;16:4089–103. - DOI
    1. Thakral NK, Meister E, Jankovsky C, Li L, Schwabe R, Luo L, et al. Prediction of in vivo supersaturation and precipitation of poorly water-soluble drugs: achievements and aspirations. Int J Pharm. 2021;600: 120505. - PubMed - DOI
    1. Ashwathy P, Anto AT, Sudheesh MS. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions. Drug Dev Ind Pharm. Taylor & Francis; 2021;47:1–11.
    1. Wilson VR, Mugheirbi NA, Mosquera-Giraldo LI, Deac A, Moseson DE, Smith DT, et al. Interaction of polymers with enzalutamide nanodroplets—impact on droplet properties and induction times. Mol Pharm American Chemical Society. 2021;18:836–49. - DOI

LinkOut - more resources